Royal Marsden NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Analysis of Pharmacodynamic Changes With AUY922A, an HSP90 Inhibitor
- Conditions
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2009-12-02
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 25
- Registration Number
- NCT01024283
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-12-01
- Last Posted Date
- 2015-11-25
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 47
- Registration Number
- NCT01022541
- Locations
- π¬π§
David Cunningham, Sutton, Surrey, United Kingdom
Patient Satisfaction in the Critical Care Unit: A Qualitative Phenomenological Study
- First Posted Date
- 2009-11-03
- Last Posted Date
- 2009-11-03
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 8
- Registration Number
- NCT01007162
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer
Not Applicable
- Conditions
- First Posted Date
- 2009-11-03
- Last Posted Date
- 2009-11-03
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 30
- Registration Number
- NCT01006564
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2009-10-28
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT01003522
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Novel Prognostic Markers in Renal Cancer
Completed
- Conditions
- First Posted Date
- 2009-10-28
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 182
- Registration Number
- NCT01002937
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
The Identification of Novel Prognostic Markers in Melanoma
- Conditions
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2009-10-27
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 500
- Registration Number
- NCT01002560
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 25
- Registration Number
- NCT01001728
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Adaptive Planning in Bladder Cancer
Phase 2
- Conditions
- First Posted Date
- 2009-10-22
- Last Posted Date
- 2009-10-22
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 32
- Registration Number
- NCT01000129
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
An Exploration of Genetic Testing for Prostate Cancer Susceptibility
- Conditions
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2009-10-19
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 200
- Registration Number
- NCT00997464
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Β© Copyright 2024. All Rights Reserved by MedPath